Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (98)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Watanabe, H.
Right arrow Articles by Sobue, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watanabe, H.
Right arrow Articles by Sobue, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 125, No. 5, 1070-1083, May 2002
© 2002 Guarantors of Brain

Progression and prognosis in multiple system atrophy

An analysis of 230 Japanese patients

Hirohisa Watanabe1, Yufuko Saito4, Shinichi Terao6, Tetsuo Ando5, Teruhiko Kachi7, Eiichiro Mukai3, Ikuko Aiba4, Yuji Abe1, Akiko Tamakoshi2, Manabu Doyu1, Masaaki Hirayama1 and Gen Sobue1

1 Department of Neurology and 2 Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, 3 Department of Neurology, Nagoya National Hospital, 4 Department of Neurology, Higashi Nagoya National Hospital, 5 Department of Neurology, Nagoya Daini Red Cross Hospital, Nagoya, 6 Division of Neurology, Department of General Medicine, Aichi Medical University and 7 Department of Neurology, Chubu National Hospital, Japan

Correspondence to: G. Sobue, Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan E-mail: sobueg{at}tsuru.med.nagoya-u.ac.jp

We investigated the disease progression and survival in 230 Japanese patients with multiple system atrophy (MSA; 131 men, 99 women; 208 probable MSA, 22 definite; mean age at onset, 55.4 years). Cerebellar dysfunction (multiple system atrophy–cerebellar; MSA-C) predominated in 155 patients, and parkinsonism (multiple system atrophy–parkinsonian; MSA-P) in 75. The median time from initial symptom to combined motor and autonomic dysfunction was 2 years (range 1–10). Median intervals from onset to aid-requiring walking, confinement to a wheelchair, a bedridden state and death were 3, 5, 8 and 9 years, respectively. Patients manifesting combined motor and autonomic involvement within 3 years of onset had a significantly increased risk of not only developing advanced disease stage but also shorter survival (P < 0.01). MSA-P patients had more rapid functional deterioration than MSA-C patients (aid-requiring walking, P = 0.03; confinement to a wheelchair, P < 0.01; bedridden state, P < 0.01), but showed similar survival. Onset in older individuals showed increased risk of confinement to a wheelchair (P < 0.05), bedridden state (P = 0.03) and death (P < 0.01). Patients initially complaining of motor symptoms had accelerated risk of aid-requiring walking (P < 0.01) and confinement to a wheelchair (P < 0.01) compared with those initially complaining of autonomic symptoms, while the time until confinement to a bedridden state and survival were no worse. Gender was not associated with differences in worsening of function or survival. On MRI, a hyperintense rim at the lateral edge of the dorsolateral putamen was seen in 34.5% of cases, and a ‘hot cross bun’ sign in the pontine basis (PB) in 63.3%. These putaminal and pontine abnormalities became more prominent as MSA-P and MSA-C features advanced. The atrophy of the cerebellar vermis and PB showed a significant correlation particularly with the interval following the appearance of cerebellar symptoms in MSA-C (r = 0.71, P < 0.01, r = 0.76 and P < 0.01, respectively), but the relationship between atrophy and functional status was highly variable among the individuals, suggesting that other factors influenced the functional deterioration. Atrophy of the corpus callosum was seen in a subpopulation of MSA, suggesting hemispheric involvement in a subgroup of MSA patients. The present study suggested that many factors are involved in the progression of MSA but, most importantly, the interval from initial symptom to combined motor and autonomic dysfunction can predict functional deterioration and survival in MSA.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
M Nakajima, H Kojima, Y Takazawa, N Yahagi, K Harada, K Takahashi, K Unuma, and K Yoshida
An autopsy report on multiple system atrophy diagnosed immunohistochemically despite severe ischaemic damage: a new approach for investigation of medical practice associated deaths in Japan
J. Clin. Pathol., November 1, 2009; 62(11): 1029 - 1033.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Tada, A. Kakita, Y. Toyoshima, O. Onodera, T. Ozawa, T. Morita, M. Nishizawa, and H. Takahashi
Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death
Brain, July 1, 2009; 132(7): 1810 - 1819.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S. Ito, W. Shirai, and T. Hattori
Putaminal Hyperintensity on T1-Weighted MR Imaging in Patients with the Parkinson Variant of Multiple System Atrophy
AJNR Am. J. Neuroradiol., April 1, 2009; 30(4): 689 - 692.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
G. Bensimon, A. Ludolph, Y. Agid, M. Vidailhet, C. Payan, P. N. Leigh, and for the NNIPPS Study Group
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study
Brain, January 1, 2009; 132(1): 156 - 171.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. S. O'Sullivan, L. A. Massey, D. R. Williams, L. Silveira-Moriyama, P. A. Kempster, J. L. Holton, T. Revesz, and A. J. Lees
Clinical outcomes of progressive supranuclear palsy and multiple system atrophy
Brain, May 1, 2008; 131(5): 1362 - 1372.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
Y. Kawai, M. Suenaga, A. Takeda, M. Ito, H. Watanabe, F. Tanaka, K. Kato, H. Fukatsu, S. Naganawa, T. Kato, et al.
Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P
Neurology, April 15, 2008; 70(16_Part_2): 1390 - 1396.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
D. Dormont, D.J. Seidenwurm, and for the Expert Panel on Neurologic Imaging
Dementia and Movement Disorders
AJNR Am. J. Neuroradiol., January 1, 2008; 29(1): 204 - 206.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M. Ito, H. Watanabe, Y. Kawai, N. Atsuta, F. Tanaka, S. Naganawa, H. Fukatsu, and G. Sobue
Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy
J. Neurol. Neurosurg. Psychiatry, July 1, 2007; 78(7): 722 - 728.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Shibao, S. R. Raj, A. Gamboa, A. Diedrich, L. Choi, B. K. Black, D. Robertson, and I. Biaggioni
Norepinephrine Transporter Blockade With Atomoxetine Induces Hypertension in Patients With Impaired Autonomic Function
Hypertension, July 1, 2007; 50(1): 47 - 53.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
T. Shimohata, H. Shinoda, H. Nakayama, T. Ozawa, K. Terajima, H. Yoshizawa, Y. Matsuzawa, O. Onodera, S. Naruse, K. Tanaka, et al.
Daytime Hypoxemia, Sleep-Disordered Breathing, and Laryngopharyngeal Findings in Multiple System Atrophy
Arch Neurol, June 1, 2007; 64(6): 856 - 861.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
K. Hara, Y. Momose, S. Tokiguchi, M. Shimohata, K. Terajima, O. Onodera, A. Kakita, M. Yamada, H. Takahashi, M. Hirasawa, et al.
Multiplex Families With Multiple System Atrophy
Arch Neurol, April 1, 2007; 64(4): 545 - 551.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S. Papapetropoulos, A. Tuchman, D. Laufer, A. G Papatsoris, N. Papapetropoulos, and D. C Mash
Causes of death in multiple system atrophy
J. Neurol. Neurosurg. Psychiatry, March 1, 2007; 78(3): 327 - 329.
[Full Text] [PDF]


Home page
Arch NeurolHome page
M. Tada, O. Onodera, M. Tada, T. Ozawa, Y.-S. Piao, A. Kakita, H. Takahashi, and M. Nishizawa
Early Development of Autonomic Dysfunction May Predict Poor Prognosis in Patients With Multiple System Atrophy
Arch Neurol, February 1, 2007; 64(2): 256 - 260.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
W. F. Abdo, B.P.C. van de Warrenburg, M. Munneke, W. J.A. van Geel, B. R. Bloem, H. P.H. Kremer, and M. M. Verbeek
CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia
Neurology, August 8, 2006; 67(3): 474 - 479.
[Abstract] [Full Text] [PDF]


Home page
PNHome page
K. S M Taylor and C. Counsell
Is it Parkinson's disease, and if not, what is it?
Practical Neurology, June 1, 2006; 6(3): 154 - 165.
[Full Text] [PDF]


Home page
BrainHome page
D. C. Paviour, S. L. Price, M. Jahanshahi, A. J. Lees, and N. C. Fox
Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy
Brain, April 1, 2006; 129(4): 1040 - 1049.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
W.-H. Lee, C.-C. Lee, W.-C. Shyu, P.-N. Chong, and S.-Z. Lin
Hyperintense Putaminal Rim Sign Is Not a Hallmark of Multiple System Atrophy at 3T
AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2238 - 2242.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. Kamm, D. G. Healy, N. P. Quinn, U. Wullner, J. C. Moller, L. Schols, F. Geser, K. Burk, A. D. Borglum, M. T. Pellecchia, et al.
The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group
Brain, August 1, 2005; 128(8): 1855 - 1860.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
N Mabuchi, M Hirayama, Y Koike, H Watanabe, H Ito, R Kobayashi, K Hamada, and G Sobue
Progression and prognosis in pure autonomic failure (PAF): comparison with multiple system atrophy
J. Neurol. Neurosurg. Psychiatry, July 1, 2005; 76(7): 947 - 952.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Shibao, A. Gamboa, A. Diedrich, and I. Biaggioni
Management of Hypertension in the Setting of Autonomic Failure: A Pathophysiological Approach
Hypertension, April 1, 2005; 45(4): 469 - 476.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
J. Hemingway, K. Franco, and E. Chmelik
Shy-Drager Syndrome: Multisystem Atrophy With Comorbid Depression
Psychosomatics, February 1, 2005; 46(1): 73 - 76.
[Full Text] [PDF]


Home page
BrainHome page
T. Ozawa, D. Paviour, N. P. Quinn, K. A. Josephs, H. Sangha, L. Kilford, D. G. Healy, N. W. Wood, A. J. Lees, J. L. Holton, et al.
The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations
Brain, December 1, 2004; 127(12): 2657 - 2671.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M B Muzaimi, J Thomas, S Palmer-Smith, L Rosser, P S Harper, C M Wiles, D Ravine, and N P Robertson
Population based study of late onset cerebellar ataxia in south east Wales
J. Neurol. Neurosurg. Psychiatry, August 1, 2004; 75(8): 1129 - 1134.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. Watanabe, H. Fukatsu, N. Hishikawa, Y. Hashizume, and G. Sobue
Field strengths and sequences influence putaminal MRI findings in multiple system atrophy
Neurology, February 24, 2004; 62(4): 671 - 671.
[Full Text] [PDF]


Home page
BrainHome page
A. A. Migliaccio, G. M. Halmagyi, L. A. McGarvie, and P. D. Cremer
Cerebellar ataxia with bilateral vestibulopathy: description of a syndrome and its characteristic clinical sign
Brain, February 1, 2004; 127(2): 280 - 293.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H Watanabe, H Fukatsu, M Katsuno, M Sugiura, K Hamada, Y Okada, M Hirayama, T Ishigaki, and G Sobue
Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker
J. Neurol. Neurosurg. Psychiatry, January 1, 2004; 75(1): 103 - 109.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C.-S. Lu, Y.-H. Weng, M.-C. Chen, R.-S. Chen, K.-Y. Tzen, S.-P. Wey, G. Ting, H.-C. Chang, and T.-C. Yen
99mTc-TRODAT-1 Imaging of Multiple System Atrophy
J. Nucl. Med., January 1, 2004; 45(1): 49 - 55.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
R Higo, N Tayama, T Watanabe, T Nitou, and S Takeuchi
Vocal fold motion impairment in patients with multiple system atrophy: evaluation of its relationship with swallowing function
J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 982 - 984.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Seppi, M.F.H. Schocke, R. Esterhammer, C. Kremser, C. Brenneis, J. Mueller, S. Boesch, W. Jaschke, W. Poewe, and G.K. Wenning
Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy
Neurology, March 25, 2003; 60(6): 922 - 927.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.